Locus Cell Co., Ltd. (TPEX:6891)
Taiwan · Delayed Price · Currency is TWD 39.20
-1.05 (-2.61%)
Sep 18, 2026, 1:58 PM CST
Locus Cell Market Cap
Locus Cell has a market cap or net worth of 7.92 billion as of September 18, 2026. Its market cap has increased by 25.95% in one year.
Market Cap
7.92B
Enterprise Value
7.84B
Revenue
19.40M
Ranking
n/a
PE Ratio
n/a
Stock Price
39.20
ChartMarket Cap Chart
Since April 28, 2022, Locus Cell's market cap has decreased from 9.88B to 7.92B, a decrease of -19.81%. That is a compound annual growth rate of -4.90%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 7.92B | 37.75% |
| Dec 31, 2025 | 5.75B | 44.14% |
| Dec 31, 2024 | 3.99B | -36.67% |
| Dec 29, 2023 | 6.30B | -12.86% |
| Dec 30, 2022 | 7.23B | -26.82% |
| Apr 28, 2022 | 9.88B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| TCM Biotech International | 10.50B |
| Polaris Group | 8.88B |
| Tanvex BioPharma | 8.61B |
| TWi Biotechnology | 8.26B |
| PharmaEngine | 7.99B |
| Acepodia | 7.69B |
| Adimmune | 7.50B |
| AnnJi Pharmaceutical | 7.09B |